Reuters logo
BRIEF-Eli Lilly announces $850 mln investment in U.S. capital projects in 2017
2017年3月24日 / 中午12点16分 / 8 个月前

BRIEF-Eli Lilly announces $850 mln investment in U.S. capital projects in 2017

March 24 (Reuters) - Eli Lilly And Co

* Lilly announces $850 million investment in U.S. capital projects in 2017

* During 2012-2016, had increased U.S manufacturing workforce by more than 1,000 employees-from 5,000 to 6,000 roles-with about 400 added in Indianapolis

* Company’s investments span facilities across its U.S. Enterprise

* Expansion is part of five-year investment by company to expand its diabetes products manufacturing operations in U.S.

* Plans for a new $85 million expansion of its Trulicity (Dulaglutide) device assembly operations in U.S.

* “On a path to launch 20 new products in a 10-year time frame”

* Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in indianapolis

* Eli Lilly and Co says more favorable tax climate could lead to additional U.S. investments

* Expansion also includes a $140 million insulin cartridge production facility Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below